- Reuters•1 hour ago
Sanofi SA said on Monday the U.S. Department of Health and Human Services approved $43.18 million in funding to accelerate the development of a Zika vaccine, as part of efforts to prevent the infection. The funding from the Biomedical Advanced Research and Development Authority (BARDA) will be used for mid-stage trials, expected to begin in the first half of 2018, and manufacturing, the French drugmaker said. Sanofi's vaccine unit, Sanofi Pasteur, said in February it intended to develop a Zika vaccine.
- Barrons.com•2 hours ago
Today, Pfizer (PFE) announced that plans to split the company in two are permanently on hold. Management has said previously that targets of all sizes are theoretically on the table - already this year, it announced it will spend ~$15B to buy Medivation (MDVN), and more transactions seem likely. A critic could argue that Pfizer is back to being the same old Pfizer as before, relying on M&A to grow and to refill its pipeline, but at the expense of growing larger in the process depending on the size of deals it chases.
- Zacks•3 hours ago
Intelligent care is where modern medicine seems to be headed with pharma and tech companies collaborating for better healthcare solutions.
NYSE - NYSE Real Time Price. Currency in USD
|Bid||38.00 x 1400|
|Ask||38.01 x 400|
|Day's Range||37.94 - 38.15|
|52wk Range||37.41 - 51.88|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||21.21|
|Avg Vol (3m)||2,454,938|
|Dividend & Yield||1.66 (4.34%)|